Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EBP | Q15125 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.35 |
| ▸ | MGLL | Q99685 | 2/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | GUSB | P08236 | 2/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 5/20 | 0.32 |
| ▸ | RAB9A | P51151 | 5/20 | 0.32 |
| ▸ | HTT | P42858 | 4/20 | 0.32 |
| ▸ | GALR3 | O60755 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5283117 | 1.00 | EBP (0.37) | EBPSIGMAR1PTGS1PTGS2MGLL | |
| SCHEMBL5293871 | 1.00 | EBP (0.37) | EBPSIGMAR1PTGS1PTGS2MGLL | |
| SCHEMBL5287249 | 1.00 | EBP (0.37) | EBPSIGMAR1PTGS1PTGS2MGLL | |
| SCHEMBL4240596 | 1.00 | EBP (0.37) | EBPSIGMAR1PTGS1PTGS2MGLL | |
| SCHEMBL5304234 | 1.00 | EBP (0.37) | EBPSIGMAR1PTGS1PTGS2MGLL | |
| SCHEMBL1501433 | 1.00 | EBP (0.37) | EBPSIGMAR1PTGS1PTGS2MGLL | |
| SCHEMBL5288026 | 1.00 | EBP (0.37) | EBPSIGMAR1PTGS1PTGS2MGLL | |
| SCHEMBL2672875 | 1.00 | EBP (0.37) | EBPSIGMAR1PTGS1PTGS2MGLL | |
| SCHEMBL4070942 | 1.00 | EBP (0.37) | EBPSIGMAR1PTGS1PTGS2MGLL | |
| SCHEMBL5295203 | 1.00 | EBP (0.37) | EBPSIGMAR1PTGS1PTGS2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118022788-A | Preparation method and application of biomass carbon coated heteropolyacid hydrogen salt catalyst | 西北大学 | 2024-05-14 | — | — | CN | claimed |
| CN-114221038-B | Preparation method of polymer solid electrolyte based on lithium metal battery | 中国民用航空飞行学院 | 2023-03-14 | — | — | CN | claimed |
| CN-115193219-A | For absorbing CO 2 Solution of gas and CO 2 Absorption and release method of | 中国科学院物理研究所 | 2022-10-18 | — | — | CN | claimed |
| CN-108690217-B | Carbon fiber recycling composition and method | 波音公司 | 2022-07-15 | — | — | CN | claimed |
| US-11377535-B2 | Carbon fiber recovery compositions and methods | THE BOEING COMPANY (US) | 2022-07-05 | — | — | US | claimed |
| CN-114649593-A | Method and electrolyte for forming solid electrolyte interface film assisted by gas additive | 中国科学院物理研究所 | 2022-06-21 | — | — | CN | claimed |
| CN-114221038-A | Preparation method of polymer solid electrolyte based on lithium metal battery | 中国民用航空飞行学院 | 2022-03-22 | — | — | CN | claimed |
| CN-110734594-B | Method for preparing emulsion polymerized styrene butadiene rubber from modified carbon black | 中国石油天然气股份有限公司 | 2022-03-01 | — | — | CN | claimed |
| CN-107835841-B | Crystallization-retarded polymer composition, additive composition influencing crystallization behavior and use, method for reducing crystallization point | 弗劳恩霍弗应用研究促进协会 | 2021-01-05 | — | — | CN | claimed |
| US-10781296-B2 | Polymer composition having delayed crystallization behavior, additive composition that influences the crystallization behavior, method for lowering the crystallization point, and use of an additive composition | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2020-09-22 | — | — | US | claimed |
| EP-2602023-A1 | Catalyst combination for the preparation of polyurethane foams | BASF SE (DE) | 2013-06-12 | — | — | EP | claimed |
| US-20120283367-A1 | ANTISTATIC THERMOPLASTIC COMPOSITIONS | BASF SE (DE) | 2012-11-08 | — | — | US | claimed |
| EP-2509459-A1 | ANTISTATIC THERMOPLASTIC COMPOSITIONS | BASF SE (DE) | 2012-10-17 | — | — | EP | claimed |
| WO-2011069960-A1 | ANTISTATIC THERMOPLASTIC COMPOSITIONS | BASF SE (DE) | 2011-06-16 | — | — | WO | claimed |
| US-7863458-B2 | Halogen-free ionic liquids | MERCK PATENT GMBH (DE) | 2011-01-04 | — | — | US | claimed |
| WO-2007088152-A1 | PROCESS FOR PREPARING ISOCYANATES | BASF SE (DE) | 2007-08-09 | — | — | WO | claimed |
| WO-2006077082-A1 | METHOD FOR SEALING ROTATING SHAFTS | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-27 | — | — | WO | claimed |
| WO-2006027070-A1 | METHOD FOR THE PRODUCTION OF HETEROCYCLIC QUATERNARY AMMONIUM COMPOUNDS AND/OR GUANIDINE COMPOUNDS HAVING HIGH PURITY | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-16 | — | — | WO | claimed |
| WO-2006027069-A1 | METHOD FOR PRODUCING HETEROCYCLIC QUATERNARY AMMONIUM AND/OR GUANIDINIUM COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-16 | — | — | WO | claimed |
| US-20050070717-A1 | Halogen-free ionic liquids | MERCK PATENT GMBH (DE) | 2005-03-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050070717-A1 | Halogen-free ionic liquids | SLC39A3, CEL, HDHD5 | EBP 212/4885SIGMAR1 1036/4885PTGS1 2740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.